Albeit in a small sample set of patients, ≥40 years of age, by focusing the analysis of B-raf V600E on protein quantitation rather than mutational status, our data suggest that the B-raf V600E expression level could be a prognostic factor for metastatic melanoma. Here, BRAF is linked to metastatic melanoma.